卡切西亚指数作为胃癌患者的预后指标的有用性
Keigo Nakashima1, Koichiro Haruki2, Teppei Kamada1
1Department of Surgery International University of Health and Welfare Hospital Tochigi Japan.
Annals of gastroenterological surgery
|September 4, 2023
概括
缓解症指数 (CXI) 预测胃癌患者的预后不佳. 这种生物标志物包括营养和炎症标志物,有助于评估改善患者管理的长期结果.
科学领域:
- 在瘤学瘤学.
- 生物标志物 生物标志物
- 胃肠病学 胃肠病学
背景情况:
- 卡切西亚显著影响癌症患者的发病率和死亡率.
- 缓解症指数 (CXI) 是一种新的生物标志物,可以显示某些癌症的预后.
- 了解CXI在胃癌中的作用对于患者的治疗结果至关重要.
研究的目的:
- 分析胃癌患者的缓解症指数 (CXI) 和长期结果之间的关系.
- 评估CXI作为胃癌的预后生物标志物.
主要方法:
- 包括175名接受治疗性胃切除术的胃癌患者.
- 使用骨肌肉指数,血清白蛋白和中性粒细胞与淋巴细胞的比率计算CXI.
- 利用单变量和多变量考克斯回归模型来评估预后价值.
主要成果:
- 低CXI是无疾病生存率 (HR,2.97) 和整体生存率 (HR,4.07) 的独立预测因素.
- 瘤的位置和疾病阶段也是生存的重要预测因素.
- 低CXI患者的BMI较低,疾病晚期,预后营养指数较差.
结论:
- 缓解症指数 (CXI) 与胃癌的预后不佳有关.
- 建议进行全面的评估,包括营养,身体和炎症状况.
- CXI可以成为预测胃癌的结果的宝贵工具.
更多相关视频
相关概念视频
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Comparing the Survival Analysis of Two or More Groups
222
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
222


